| Schedule of EPS amounts for all periods and the basic and diluted weighted-average shares outstanding used in the calculation |
| | | | | | | | | | | | | | | For the Three Months Ended | | For the Six Months Ended | | | June 30, | | June 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | | | (In thousands, except per share amounts) | Net income (loss) | | $ | (306,844) | | $ | (207,458) | | $ | (510,125) | | $ | (315,833) | Less: Net income (loss) attributable to noncontrolling interests, net of tax | | | (712) | | | (1,867) | | | (1,324) | | | (2,866) | Net income (loss) attributable to EchoStar - Basic | | | (306,132) | | | (205,591) | | | (508,801) | | | (312,967) | Interest on dilutive Convertible Notes, net of tax (1) | | | — | | | — | | | — | | | — | Net income (loss) attributable to EchoStar - Diluted | | $ | (306,132) | | $ | (205,591) | | $ | (508,801) | | $ | (312,967) | | | | | | | | | | | | | | Weighted-average common shares outstanding - Class A and B common stock: | | | | | | | | | | | | | Basic (2) | | | 287,505 | | | 271,592 | | | 287,012 | | | 271,555 | Dilutive impact of Convertible Notes (1) | | | — | | | — | | | — | | | - | Dilutive impact of stock awards outstanding (1) | | | — | | | — | | | — | | | — | Diluted | | | 287,505 | | | 271,592 | | | 287,012 | | | 271,555 | | | | | | | | | | | | | | Earnings per share - Class A and B common stock: | | | | | | | | | | | | | Basic net income (loss) per share attributable to EchoStar | | $ | (1.06) | | $ | (0.76) | | $ | (1.77) | | $ | (1.15) | Diluted net income (loss) per share attributable to EchoStar | | $ | (1.06) | | $ | (0.76) | | $ | (1.77) | | $ | (1.15) |
| (1) | For the three and six months ended June 30, 2025 and 2024, the interest on dilutive Convertible Notes and the dilutive impact of weighted-average shares of Class A common stock were excluded from the computation of “Diluted net income (loss) per share attributable to EchoStar” because the effect would have been anti-dilutive as a result of the net loss attributable to EchoStar in the period. As of June 30, 2025 and 2024, our Convertible Notes may be converted into 58 million shares and 33 million shares, respectively. |
| (2) | On November 12, 2024, we issued and sold 14.265 million shares of our Class A Common Stock to certain PIPE investors. |
|
| Schedule of anti-dilutive securities not included in the diluted EPS calculation |
| | | | | | | As of June 30, | | | 2025 | | 2024 | | | | (In thousands) | Anti-dilutive stock awards | | 3,724 | | 9,762 | Performance/market based options | | 4,257 | | 4,421 | Common stock warrants | | 16,151 | | 16,151 | Total | | 24,132 | | 30,334 |
|